Evidence map›Paper›PMID 30250990›Full record

ReviewMolecular imaging and biology2018

Current and Emerging Preclinical Approaches for Imaging-Based Characterization of Atherosclerosis.

Jonathan Vigne, James Thackeray, Jeroen Essers, Marcus Makowski, Zoreh Varasteh, Adelina Curaj, Angelos Karlas, Emmanuel Canet-Soulas, Willem Mulder, Fabian Kiessling and 5 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular imaging and biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Preclinical techniques to investigate exercise training in vascular pathophysiology.American journal of physiology. Heart and circulatory physiology · 2021
    Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Identifying the leukocyte uptake pattern of inflammation imaging agents: Current limitations and potential impact.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
  7. Impact of optimized PET imaging conditions onJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
  8. Article
  9. Article
  10. [ACS medicinal chemistry letters · 2020
    Article
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Jonathan VigneDepartment of Nuclear Medicine, Bichat University Hospital, AP-HP; INSERM, U-1148, DHU FIRE, University Diderot, Paris, France.
James ThackerayDepartment of Nuclear Medicine, Hannover Medical School, Hannover, Germany.
Jeroen EssersDepartments of Vascular Surgery, Molecular Genetics, Radiation Oncology, Erasmus MC, Rotterdam, The Netherlands.
Marcus MakowskiDepartment of Radiology, Charité-University Medicine Berlin, Berlin, Germany.
Zoreh VarastehDepartment of Nuclear Medicine, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
Adelina CurajInstitute for Molecular Cardiovascular Research (IMCAR), Institute for Experimental Molecular Imaging (ExMI), University Hospital Aachen, RWTH, Aachen, Germany.
Angelos KarlasInstitute for Biological and Medical Imaging, Helmholtz Zentrum München, Oberschleissheim, Germany.
Emmanuel Canet-SoulasLaboratoire CarMeN, INSERM U-1060, Lyon/Hospices Civils Lyon, IHU OPERA Cardioprotection, Université de Lyon, Bron, France.
Willem MulderTranslational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, Mount Sinai, New York, USA.
Fabian KiesslingInstitute for Experimental Molecular Imaging (ExMI), University Hospital Aachen, RWTH, Aachen, Germany.
Michael SchäfersDepartment of Nuclear Medicine, European Institute for Molecular Imaging (EIMI), Westfälische Wilhelms-Universität Münster, Münster, Germany.
René BotnarSchool of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Moritz WildgruberTranslational Research Imaging Center, Institut für Klinische Radiologie, Universitätsklinikum Münster, Albert-Schweitzer-Campus 1, 48149, Münster, Germany.
Fabien HyafilDepartment of Nuclear Medicine, Bichat University Hospital, AP-HP; INSERM, U-1148, DHU FIRE, University Diderot, Paris, France. fabien.hyafil@aphp.fr.ORCID http://orcid.org/0000-0002-9600-0376
Cardiovascular study group of the European Society of Molecular Imaging

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atherosclerotic plaques can remain quiescent for years, but become life threatening upon rupture or disruption, initiating clot formation in the vessel lumen and causing acute myocardial infarction and ischemic stroke. Whether and how a plaque ruptures is determined by its macroscopic structure and microscopic composition. Rupture-prone plaques usually consist of a thin fibrous cap with few smooth muscle cells, a large lipid core, a dense infiltrate of inflammatory cells, and neovessels. Such lesions, termed high-risk plaques, can remain asymptomatic until the thrombotic event. Various imaging technologies currently allow visualization of morphological and biological characteristics of high-risk atherosclerotic plaques. Conventional protocols are often complex and lack specificity for high-risk plaque. Conversely, new imaging approaches are emerging which may overcome these limitations. Validation of these novel imaging techniques in preclinical models of atherosclerosis is essential for effective translational to clinical practice. Imaging the vessel wall, as well as its biological milieu in small animal models, is challenging because the vessel wall is a small structure that undergoes continuous movements imposed by the cardiac cycle as it is adjacent to circulating blood. The focus of this paper is to provide a state-of-the-art review on techniques currently available for preclinical imaging of atherosclerosis in small animal models and to discuss the advantages and limitations of each approach.

Indexed as

Molecular ImagingAnimalsAtherosclerosisDisease Models, AnimalHumansMagnetic Resonance ImagingOptical ImagingUltrasonicsAtherosclerosisImaging-based characterizationPreclinical approaches

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.